Sherri Patterson

3.4k total citations
12 papers, 504 citations indexed

About

Sherri Patterson is a scholar working on Pharmacology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sherri Patterson has authored 12 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sherri Patterson's work include Inflammatory mediators and NSAID effects (6 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Sherri Patterson is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Sherri Patterson collaborates with scholars based in United States, Canada and Denmark. Sherri Patterson's co-authors include Ernest T. Hawk, Patrick M. Lynch, Xiangwei Wu, Ilan R. Kirsch, Kenneth Nakahara, Jean Jenkins, John Denobile, Henry T. Lynch, Luz M. Rodriguez and Aby Buchbinder and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer Research and Gut.

In The Last Decade

Sherri Patterson

11 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherri Patterson United States	9	233	186	148	85	72	12	504
Jin Shi China	14	207 0.9×	160 0.9×	202 1.4×	55 0.6×	108 1.5×	33	638
Valérie Le Morvan France	18	310 1.3×	77 0.4×	389 2.6×	50 0.6×	113 1.6×	45	745
N. Lee United States	12	141 0.6×	58 0.3×	142 1.0×	88 1.0×	114 1.6×	51	563
Quan Jiang China	15	169 0.7×	67 0.4×	213 1.4×	43 0.5×	115 1.6×	30	534
Junko Baba Japan	5	216 0.9×	88 0.5×	237 1.6×	32 0.4×	112 1.6×	5	548
Steven Goldschmid United States	6	146 0.6×	68 0.4×	234 1.6×	84 1.0×	63 0.9×	6	504
Qixing Tan China	13	166 0.7×	68 0.4×	224 1.5×	94 1.1×	66 0.9×	33	570
Sonam Tulsyan India	15	218 0.9×	33 0.2×	283 1.9×	85 1.0×	73 1.0×	24	600
Xiaoping Chen China	14	244 1.0×	31 0.2×	203 1.4×	61 0.7×	52 0.7×	32	520
Jayashri Kidao United States	3	421 1.8×	212 1.1×	199 1.3×	114 1.3×	307 4.3×	3	713

Countries citing papers authored by Sherri Patterson

Since Specialization

Citations

This map shows the geographic impact of Sherri Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherri Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherri Patterson more than expected).

Fields of papers citing papers by Sherri Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherri Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherri Patterson. The network helps show where Sherri Patterson may publish in the future.

Co-authorship network of co-authors of Sherri Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Sherri Patterson. A scholar is included among the top collaborators of Sherri Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherri Patterson. Sherri Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Essebag, Vidal, Zahra Azizi, Pouria Alipour, et al.. (2020). Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study. EP Europace. 22(7). 1017–1025. 14 indexed citations

Essebag, Vidal, Zahra Azizi, Pouria Alipour, et al.. (2019). Comparison of efficacy of phased multipolar versus traditional radiofrequency ablation: A prospective, multicenter study (CAPCOST). Pacing and Clinical Electrophysiology. 42(7). 942–950. 5 indexed citations

Azizi, Zahra, Atul Verma, Pouria Alipour, et al.. (2018). QUALITY OF LIFE POST AF ABLATION AND RELATIONSHIP TO OUTCOME AND AF BURDEN. Journal of the American College of Cardiology. 71(11). A379–A379.

Lynch, Patrick M., Carol A. Burke, Robin Phillips, et al.. (2015). An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 65(2). 286–295. 75 indexed citations

Menter, David G., Sherri Patterson, Craig D. Logsdon, et al.. (2014). Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?. Cancer Prevention Research. 7(10). 973–992. 8 indexed citations

Patterson, Sherri, Karen Colbert Maresso, & Ernest T. Hawk. (2012). Cancer Chemoprevention: Successes and Failures. Clinical Chemistry. 59(1). 94–101. 36 indexed citations

Wu, Xiangwei, Sherri Patterson, & Ernest T. Hawk. (2011). Chemoprevention – History and general principles. Best Practice & Research Clinical Gastroenterology. 25(4-5). 445–459. 41 indexed citations

Lynch, Patrick M., Gregory D. Ayers, Ellen Richmond, et al.. (2010). The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis. The American Journal of Gastroenterology. 105(6). 1437–1443. 57 indexed citations

Brewster, Abenaa M., Sherri Patterson, Michele R. Forman, et al.. (2010). Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cancer Prevention Research. 3(8). 1044–1048. 3 indexed citations

10.

Glebov, O K, Luz M. Rodriguez, Patrick M. Lynch, et al.. (2006). Celecoxib Treatment Alters the Gene Expression Profile of Normal Colonic Mucosa. Cancer Epidemiology Biomarkers & Prevention. 15(7). 1382–1391. 20 indexed citations

11.

Xiao, Zhen, Brian T. Luke, Grant Izmirlian, et al.. (2004). Serum Proteomic Profiles Suggest Celecoxib-Modulated Targets and Response Predictors. Cancer Research. 64(8). 2904–2909. 25 indexed citations

12.

Glebov, O K, Luz M. Rodriguez, Kenneth Nakahara, et al.. (2003). Distinguishing right from left colon by the pattern of gene expression.. PubMed. 12(8). 755–62. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact